102 related articles for article (PubMed ID: 21091766)
1. Melatonin and vitamin D3 synergistically down-regulate Akt and MDM2 leading to TGFβ-1-dependent growth inhibition of breast cancer cells.
Proietti S; Cucina A; D'Anselmi F; Dinicola S; Pasqualato A; Lisi E; Bizzarri M
J Pineal Res; 2011 Mar; 50(2):150-8. PubMed ID: 21091766
[TBL] [Abstract][Full Text] [Related]
2. Melatonin down-regulates MDM2 gene expression and enhances p53 acetylation in MCF-7 cells.
Proietti S; Cucina A; Dobrowolny G; D'Anselmi F; Dinicola S; Masiello MG; Pasqualato A; Palombo A; Morini V; Reiter RJ; Bizzarri M
J Pineal Res; 2014 Aug; 57(1):120-9. PubMed ID: 24920214
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a biphasic apoptotic pathway induced by melatonin in MCF-7 breast cancer cells.
Cucina A; Proietti S; D'Anselmi F; Coluccia P; Dinicola S; Frati L; Bizzarri M
J Pineal Res; 2009 Mar; 46(2):172-80. PubMed ID: 19175854
[TBL] [Abstract][Full Text] [Related]
4. Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells.
Yang L; Yang J; Venkateswarlu S; Ko T; Brattain MG
J Cell Physiol; 2001 Sep; 188(3):383-93. PubMed ID: 11473365
[TBL] [Abstract][Full Text] [Related]
5. Melatonin induces the apoptosis and inhibits the proliferation of human gastric cancer cells via blockade of the AKT/MDM2 pathway.
Song J; Ma SJ; Luo JH; Zhang H; Wang RX; Liu H; Li L; Zhang ZG; Zhou RX
Oncol Rep; 2018 Apr; 39(4):1975-1983. PubMed ID: 29484412
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous modulation of COX-2, p300, Akt, and Apaf-1 signaling by melatonin to inhibit proliferation and induce apoptosis in breast cancer cells.
Wang J; Xiao X; Zhang Y; Shi D; Chen W; Fu L; Liu L; Xie F; Kang T; Huang W; Deng W
J Pineal Res; 2012 Aug; 53(1):77-90. PubMed ID: 22335196
[TBL] [Abstract][Full Text] [Related]
7. Combined targeting of epidermal growth factor receptor and MDM2 by gefitinib and antisense MDM2 cooperatively inhibit hormone-independent prostate cancer.
Bianco R; Caputo R; Caputo R; Damiano V; De Placido S; Ficorella C; Agrawal S; Bianco AR; Ciardiello F; Tortora G
Clin Cancer Res; 2004 Jul; 10(14):4858-64. PubMed ID: 15269162
[TBL] [Abstract][Full Text] [Related]
8. Novel Gemini-vitamin D3 analog inhibits tumor cell growth and modulates the Akt/mTOR signaling pathway.
O'Kelly J; Uskokovic M; Lemp N; Vadgama J; Koeffler HP
J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):107-16. PubMed ID: 16777406
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of AKT and MDM2, Melatonin Induces Apoptosis in AGS and MGC803 Cells.
Song J; Ma SJ; Luo JH; Liu H; Li L; Zhang ZG; Chen LS; Zhou RX
Anat Rec (Hoboken); 2019 Sep; 302(9):1544-1551. PubMed ID: 30809951
[TBL] [Abstract][Full Text] [Related]
10. All trans-retinoic acid acts synergistically with hydroxytamoxifen and transforming-growth factor beta to stimulate apoptosis in MCF-7 breast cancer cells.
Danforth DN
J Endocrinol; 2004 Nov; 183(2):395-404. PubMed ID: 15531727
[TBL] [Abstract][Full Text] [Related]
11. PP2A mediates diosmin p53 activation to block HA22T cell proliferation and tumor growth in xenografted nude mice through PI3K-Akt-MDM2 signaling suppression.
Dung TD; Day CH; Binh TV; Lin CH; Hsu HH; Su CC; Lin YM; Tsai FJ; Kuo WW; Chen LM; Huang CY
Food Chem Toxicol; 2012 May; 50(5):1802-10. PubMed ID: 22289577
[TBL] [Abstract][Full Text] [Related]
12. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
13. Akt regulates vitamin D3-induced leukemia cell functional differentiation via Raf/MEK/ERK MAPK signaling.
Wang J; Zhao Y; Kauss MA; Spindel S; Lian H
Eur J Cell Biol; 2009 Feb; 88(2):103-15. PubMed ID: 19058874
[TBL] [Abstract][Full Text] [Related]
14. Dose-response transition from cell cycle arrest to apoptosis with selective degradation of Mdm2 and p21WAF1/CIP1 in response to the novel anticancer agent, aminoflavone (NSC 686,288).
Meng LH; Kohn KW; Pommier Y
Oncogene; 2007 Jul; 26(33):4806-16. PubMed ID: 17297446
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase C epsilon confers resistance of MCF-7 cells to TRAIL by Akt-dependent activation of Hdm2 and downregulation of p53.
Shankar E; Sivaprasad U; Basu A
Oncogene; 2008 Jun; 27(28):3957-66. PubMed ID: 18317451
[TBL] [Abstract][Full Text] [Related]
16. Wogonin induces apoptosis and down-regulates survivin in human breast cancer MCF-7 cells by modulating PI3K-AKT pathway.
Huang KF; Zhang GD; Huang YQ; Diao Y
Int Immunopharmacol; 2012 Feb; 12(2):334-41. PubMed ID: 22182776
[TBL] [Abstract][Full Text] [Related]
17. SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival.
Fenouille N; Puissant A; Tichet M; Zimniak G; Abbe P; Mallavialle A; Rocchi S; Ortonne JP; Deckert M; Ballotti R; Tartare-Deckert S
Oncogene; 2011 Dec; 30(49):4887-900. PubMed ID: 21685937
[TBL] [Abstract][Full Text] [Related]
18. Antisense anti-MDM2 oligonucleotides as a novel therapeutic approach to human breast cancer: in vitro and in vivo activities and mechanisms.
Wang H; Nan L; Yu D; Agrawal S; Zhang R
Clin Cancer Res; 2001 Nov; 7(11):3613-24. PubMed ID: 11705884
[TBL] [Abstract][Full Text] [Related]
19. [Impact of PI3K /Akt /mdm2 signaling pathway on the sensitivity of gastric cancer cell line SGC7901 to doxorubicin].
Ai YW; Yu HG; Yu JP; Yang Y; Li H; Hu XW; Luo HS
Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):494-7. PubMed ID: 19062713
[TBL] [Abstract][Full Text] [Related]
20. Gossypol inhibits the growth of MAT-LyLu prostate cancer cells by modulation of TGFbeta/Akt signaling.
Jiang J; Ye W; Lin YC
Int J Mol Med; 2009 Jul; 24(1):69-75. PubMed ID: 19513537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
